The only medication currently approved for stroke treatment – tissue plasminogen activator (tPA), which dissolves blood clots – is associated with an increased risk of bleeding in the brain, particularly among patients with hyperglycemia (high blood sugar).

Triple-negative breast cancer is the most deadly form of the disease. This form of breast cancer has a disproportionate impact on women who are younger, African American or Hispanic, but new discoveries, including a new treatment approach targeting inflammation in cancer, may help women survive the disease.

The University of California Center for Health Quality and Innovation is accepting applications for the UC Health Fellowship.

Bryan Stow is now recovering after being treated for a severe brain injury at the UCSF-affiliated San Francsico General Hospital and Trauma Center, which recently became the first hospital in the country to be certified for a Traumatic Brain Injury Program by the Joint Commission.

UCSF Medical Center at Mission Bay will celebrate a major milestone on October 17, with the placement of a 1,600-pound beam atop the sprawling hospital complex to signify the end of the structural steel phase.

John Baxter, a UCSF faculty member for more than 35 years, is being remembered as a pioneer of biotechnology and a leader in taking discoveries from the halls of academia to form companies aimed at developing medical therapies. He died in San Francisco on Oct. 5 following surgery for cancer.